The entire axis CXCR4–CXCL12–CXCR7 regulates the mammalian target of rapamycin (mTOR) signaling in renal cancer cells, a pathway identified in several human malignancies and effectively blocked by peptide R in these cells [45]. Here, ACKR3 is linked to renal carcinoma.